Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms

The authors present the first study involving patients and healthy volunteers and providing first evidence linking endocannabinoids and tryptophan pathways to depression, stress, and inflammation (January 2024).

Read the article in BMC Medicine